Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

4 results about "Cystatin C" patented technology

Cystatin C or cystatin 3 (formerly gamma trace, post-gamma-globulin, or neuroendocrine basic polypeptide), a protein encoded by the CST3 gene, is mainly used as a biomarker of kidney function. Recently, it has been studied for its role in predicting new-onset or deteriorating cardiovascular disease. It also seems to play a role in brain disorders involving amyloid (a specific type of protein deposition), such as Alzheimer's disease. In humans, all cells with a nucleus (cell core containing the DNA) produce cystatin C as a chain of 120 amino acids. It is found in virtually all tissues and body fluids. It is a potent inhibitor of lysosomal proteinases (enzymes from a special subunit of the cell that break down proteins) and probably one of the most important extracellular inhibitors of cysteine proteases (it prevents the breakdown of proteins outside the cell by a specific type of protein degrading enzymes). Cystatin C belongs to the type 2 cystatin gene family.

Application of combination of pollen pini aqueous extract and fucoidin in preparation of medicine for preventing and / or treating renal injury

The invention belongs to the technical field of medicines, and particularly relates to combined application of a pollen pini aqueous extract and fucoidin in preparation of a medicine for preventing and / or treating renal injury. According to the invention, cell experiment results show that the combination of the pollen pini aqueous extract and the fucoidin has an obvious synergistic effect, the relative activity of HK-2 cells can be obviously improved, the cell apoptosis and ROS level caused by adriamycin can be reduced, and the energy metabolism function of the HK-2 cells can be obviously improved; animal experiment results show that the combination of the pollen pini aqueous extract and the fucoidin can significantly reduce the levels of serum creatinine (Crea), urea nitrogen (Urea) and cystatin C (Cys-C), improve the pathological injury of kidney tissues, relieve the fibrosis process, and provide a theoretical basis and an innovative direction for developing a new strategy for intervention of kidney injury.
Owner:YANTAI NEW ERA HEALTH IND

Blood metabolite markers for estimating glomerular filtration rate (GFR) and uses thereof

The present application relates to a kind of blood metabolic markers for estimating glomerular filtration rate (GFR) and its application, which includes hydroxy asparagine, and does not include creatinine.The present application successfully identifies new GFR significantly related metabolites by using strict two-center study design, and further determines two new metabolite marker combinations for constructing equations, so that GFR can be reliably estimated without creatinine, cystatin C and population statistics information and clinical feature information (such as race, gender, weight, etc.), and can be used for the development of rapid, convenient and accurate diagnostic kit.
Owner:彭洪泉

An electrochemical sensor for detecting cystatin C, a preparation method thereof, and a method for detecting cystatin C

PendingCN122282910AAptamerIn vivo
This invention discloses an electrochemical sensor for detecting Cys C, its preparation method, and a method for detecting Cys C. The electrochemical sensor for detecting Cys C includes a working electrode, a reference electrode, and a counter electrode. The working electrode comprises an electrode substrate and nanomaterials and a Cys C aptamer sequentially modified on the electrode substrate. The nanomaterials are MoS2 nanomaterials or gold nanomaterials. The 5′ end of the Cys C aptamer is modified with an electroactive substance X, where X is ferrocene or methylene blue. The 3′ end of the Cys C aptamer is modified with a group Y, where Y is -(CH2). n -SH, where n is a natural number from 1 to 12. The electrochemical sensor of this invention can be used for in vivo quantitative detection of Cys C, and exhibits good performance in terms of cost-effectiveness, ease of operation, and the use of environmentally friendly materials. It is a potential electrochemical sensor for early diagnosis of CKD.
Owner:PEKING UNIV

Physiological age prediction model based on physical examination indicators and its application

This invention provides a physiological age prediction model that predicts the physiological age of a subject by detecting physical examination indicators. These indicators include measurements of blood cells, glucose metabolism, tumor markers, urine components, anthropometric measurements, lipids, blood components, and tissue function. Preferably, these indicators include one or more selected from the following: glomerular filtration rate (eGFR), cystatin C, serum creatinine (SCr), blood urea nitrogen (BUN), timed up and go, light reaction time, fasting blood glucose (FBG), insulin-like growth factor (IGF), superoxide dismutase (SOD), insulin (INS), albumin (Alb), alkaline phosphatase (ALP), folic acid, lactate dehydrogenase (LDH), aspartate aminotransferase (AST), and high-sensitivity C-reactive protein (hs-CRP). More preferably, all of the aforementioned physical examination indicators are included. This invention also provides a physiological age prediction device applying the above-mentioned physiological age prediction model and a computer storage medium.
Owner:BEIJING HOSPITAL